AJP - Heart and Circulatory Physiology, Vol 272, Issue 6 2746-H2756, Copyright © 1997 by American Physiological Society

ARTICLES

VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor

M. G. Sirois and E. R. Edelman
Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge 02139, USA.

Vascular endothelial growth factor (VEGF), a protein synthesized and secreted by a variety of normal and neoplastic cells, serves as an endothelial cell-specific mitogen and a potent angiogenic factor. Intradermal injection of VEGF increases vascular permeability, a critical event in inflammation and angiogenesis. We sought to identify which tissues are responsive to the inflammatory effect of VEGF, to investigate the mechanisms by which VEGF increases vascular permeability, and to establish whether mediators of inflammation such as platelet-activating factor (PAF) play a role in this regard. Intravenous injection of VEGF (0.001-0.1 nmol/kg) into rats induced dose-dependent protein extravasation in vascular beds of certain tissues up to 177% over control levels. In some tissues, the elevation in vascular permeability in vivo was abolished completely by selective PAF-receptor antagonists. Moreover, VEGF (10(-11) to 10(-9) M) was found to increase PAF synthesis in cultured bovine aortic endothelial cells up to 20-fold. Our results suggest that VEGF increases vascular permeability by inducing PAF synthesis.

This article has been cited by other articles:

				T. Mirzapoiazova, I. Kolosova, P. V. Usatyuk, V. Natarajan, and A. D. Verin Diverse effects of vascular endothelial growth factor on human pulmonary endothelial barrier and migration Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L718 - L724. [Abstract] [Full Text] [PDF]

				M. Mura, C. C. dos Santos, D. Stewart, and M. Liu Vascular endothelial growth factor and related molecules in acute lung injury J Appl Physiol, November 1, 2004; 97(5): 1605 - 1617. [Abstract] [Full Text] [PDF]

				D. D. Deo, T. W. Axelrad, E. G. Robert, V. Marcheselli, N. G. Bazan, and J. D. Hunt Phosphorylation of STAT-3 in Response to Basic Fibroblast Growth Factor Occurs through a Mechanism Involving Platelet-activating Factor, JAK-2, and Src in Human Umbilical Vein Endothelial Cells. EVIDENCE FOR A DUAL KINASE MECHANISM J. Biol. Chem., June 7, 2002; 277(24): 21237 - 21245. [Abstract] [Full Text] [PDF]

				R. Beliveau, D. Gingras, E. A. Kruger, S. Lamy, P. Sirois, B. Simard, M. G. Sirois, L. Tranqui, F. Baffert, E. Beaulieu, et al. The Antiangiogenic Agent Neovastat (Ae-941) Inhibits Vascular Endothelial Growth Factor-mediated Biological Effects Clin. Cancer Res., April 1, 2002; 8(4): 1242 - 1250. [Abstract] [Full Text] [PDF]

				M. Arese, C. Ferrandi, L. Primo, G. Camussi, and F. Bussolino HIV-1 Tat Protein Stimulates In Vivo Vascular Permeability and Lymphomononuclear Cell Recruitment J. Immunol., January 15, 2001; 166(2): 1380 - 1388. [Abstract] [Full Text] [PDF]

				G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF]

				R. J. Kaner, J. V. Ladetto, R. Singh, N. Fukuda, M. A. Matthay, and R. G. Crystal Lung Overexpression of the Vascular Endothelial Growth Factor Gene Induces Pulmonary Edema Am. J. Respir. Cell Mol. Biol., June 1, 2000; 22(6): 657 - 664. [Abstract] [Full Text]

				D. KENT, S. A VINORES, and P. A CAMPOCHIARO Macular oedema: the role of soluble mediators Br. J. Ophthalmol., May 1, 2000; 84(5): 542 - 545. [Full Text]

				P. M. Becker, A. Alcasabas, A. Y. Yu, G. L. Semenza, and T. E. Bunton Oxygen-Independent Upregulation of Vascular Endothelial Growth Factor and Vascular Barrier Dysfunction during Ventilated Pulmonary Ischemia in Isolated Ferret Lungs Am. J. Respir. Cell Mol. Biol., March 1, 2000; 22(3): 272 - 279. [Abstract] [Full Text]

				P. N. Bernatchez, S. Soker, and M. G. Sirois Vascular Endothelial Growth Factor Effect on Endothelial Cell Proliferation, Migration, and Platelet-activating Factor Synthesis Is Flk-1-dependent J. Biol. Chem., October 22, 1999; 274(43): 31047 - 31054. [Abstract] [Full Text] [PDF]

				S. G. Greenberg and K. E. Clark Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1999; 277(4): R996 - R1001. [Abstract] [Full Text] [PDF]

				L. Poliakova, I. Kovesdi, X. Wang, M. C. Capogrossi, and M. Talan VASCULAR PERMEABILITY EFFECT OF ADENOVIRUS-MEDIATED VASCULAR ENDOTHELIAL GROWTH FACTOR GENE TRANSFER TO THE RABBIT AND RAT SKELETAL MUSCLE J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 339 - 347. [Abstract] [Full Text] [PDF]

				W. Zheng, M. D. Brown, T. A. Brock, R. J. Bjercke, and R. J. Tomanek Bradycardia-Induced Coronary Angiogenesis Is Dependent on Vascular Endothelial Growth Factor Circ. Res., July 23, 1999; 85(2): 192 - 198. [Abstract] [Full Text] [PDF]

				W. G. Mayhan VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway Am J Physiol Cell Physiol, May 1, 1999; 276(5): C1148 - C1153. [Abstract] [Full Text] [PDF]

				W. G. Mayhan and K. P. Patel Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1895 - H1901. [Abstract] [Full Text] [PDF]